Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
Metastatic colorectal cancers with BRAF mutation are a class of tumors that have a poor prognosis compared to wild type patients. Even if this group has found some hope in targeted therapy with multi-targeted blockade of the mitogen-activated protein kinase (MAPK) signalling pathway, more work must...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Society of Gastrointestinal Intervention,
2024-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|